Trial Profile
A Randomized, Open-label, 3-way Crossover Clinical Trial to Compare The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 May 2017
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Ildong Pharmaceutical
- 21 May 2014 New trial record